期刊文献+

内源性大麻素及其受体在神经病理痛治疗中的研究进展 被引量:1

Progress in study on endocannabinoids and cannabinoid receptors in the treatment for neuropathic pain
下载PDF
导出
摘要 在神经病理痛的发生、发展和维持中,内源性大麻素系统在神经系统从定位到表达水平都发生着动态变化。这些变化存在有利的一面,也存在不利的一面。外源性给予内源性大麻素在不同的疼痛模型中都产生了镇痛作用,且通过阻断大麻素受体发现内源性大麻素镇痛作用的发挥主要由大麻素CB1及CB2受体介导。抑制内源性大麻素降解酶在不同的疼痛模型中也表现出了镇痛作用,这种作用主要是因为增加了局部内源性大麻素含量水平。 Endocannabinoids and cannabinoid receptors are expressed in various central pain modulation regions. ~hey maintain in dynamic changes in the expression level and distribution under different pathological and physiological conditions. These changes possess advantage as well as disadvantage. Exogenous administration of endocannabinoids exerts analgesic effect in different pain models, which is mainly mediated by the cannabinoid CB1 and CB2 receptors. Inhibition of enzymes for degrading endocannabinoids in different pain models also shows analgesic effect due to the increased local levels of endocannabinoids.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2016年第8期879-884,共6页 Journal of Central South University :Medical Science
基金 国家自然科学基金(81371230) 甘肃省自然科学基金(1208RJZA267)~~
关键词 神经病理痛 内源性大麻素 大麻素受体 neuropathic pain endocannabinoids cannabinoid receptors
  • 相关文献

参考文献36

  • 1Rahn EJ, Hohmann AG. Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside[J]. Neurotherapeutics, 2009, 6(4): 713-737. 被引量:1
  • 2Pertwee RG. Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities[J]. Philos Trans R Soc Lond B Biol Sci, 2012, 367( 1607): 3353-3363. 被引量:1
  • 3Starowicz K, Di Marzo V. Non-psychotropic analgesic drugs from the endocannabinoid system: "magic bullet" or" multiple- target" strategies?E J]. EurJ Pharmacol, 2013, 716(1/2/3): 41- 53. 被引量:1
  • 4Davis MP. Cannabinoids in pain management: CB1, CB2 and non- classic receptor ligands[J]. Expert Opin Investig Drugs, 2014, 23(8): 1123-1140. 被引量:1
  • 5Starowicz K, Przewlocka B. Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system[J]. Philos Trans R Soc Lond B Biol Sci, 2012, 367(1607): 3286-3299. 被引量:1
  • 6Di Marzo V. Targeting the endocannabinoid system: to enhance or reduce?[J]. Nat Rev Drug Discov, 2008, 7(5): 438-455. 被引量:1
  • 7Lau BK, Vaughan CW. Targeting the endogenous cannabinoid system to treat neuropathic pain[J]. Front Pharmacol, 2014, 8: 28. 被引量:1
  • 8Hohmann AG, Suplita RL, Bohon NM, et al. An endocannabinoid mechanism for stress-induced analgesia[J]. Nature, 2005, 435(7045): 1108-1112. 被引量:1
  • 9Walker JM, Huang SM, Strangman NM, et al. Pain modulation by release of the endogenous cannabinoid anandamide[J]. Proc Natl Acad Sci USA, 1999, 96(21): 12198-12203. 被引量:1
  • 10Jhaveri MD, Richardson D, Kendall DA, et al. Analgesic effects of fatty acid amide hydrolase inhibition in a rat model of neuropathic pain [J]. J Neurosci, 2006, 26 (S 1): 13318-13327. 被引量:1

同被引文献19

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部